Evidence map›Paper›PMID 36329576›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2022

[SOX2-OT/SOX2 axis regulates lung cancer H520 cell migration

Hongliang Dong, Lili Zeng, Yan Wu, Shuang Miao, Na Ni, Naiguo Liu, Weiwei Chen, Jing DU

Abstract readEnglish Abstract
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hongliang DongMedical Research Center, Binzhou Medical University Hospital, Binzhou 256600, China.
Lili ZengMedical Research Center, Binzhou Medical University Hospital, Binzhou 256600, China.
Yan WuMedical Research Center, Binzhou Medical University Hospital, Binzhou 256600, China.
Shuang MiaoMedical Research Center, Binzhou Medical University Hospital, Binzhou 256600, China.
Na NiMedical Research Center, Binzhou Medical University Hospital, Binzhou 256600, China.
Naiguo LiuMedical Research Center, Binzhou Medical University Hospital, Binzhou 256600, China.
Weiwei ChenMedical Research Center, Binzhou Medical University Hospital, Binzhou 256600, China.
Jing DUMedical Research Center, Binzhou Medical University Hospital, Binzhou 256600, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the regulatory role of SOX2-OT in migration of lung squamous cell carcinoma H520 cells and the underlying mechanisms.

methodsWound- healing and Transwell migration assays were performed to examine the changes in migration and invasion capacity of lung squamous cell line H520, which expressed higher levels of SOX2-OT than other lung cancer cell lines, following RNA interference-mediated SOX2-OT knockdown. The transcription levels of epithelial-mesenchymal transition (EMT)-related components was detected by qRT-PCR and immunoblotting. Gli1 gain-of-function analysis was performed in H520 cells with SOX2-OT knockdown and the changes in EMT phenotype of the cells were examined. miR-200c mimic and inhibitor were used to analyze the mechanism by which SOX2-OT positively regulates Gli1 and the mediating role of SOX2.

resultsSOX2-OT knockdown significantly lowered the invasiveness and migration capacity of H520 cells and caused changes in EMT phenotype of the cells. Overexpression of Gli1, which was positively regulated by SOX2-OT, reversed the inhibitory effect of SOX2-OT knockdown on migration of H520 cells. Transfection of the cells with miR-200c inhibitor effectively reversed SOX2-OT knockdown-induced down-regulation of SOX2.

conclusionThe SOX2-OT/SOX2 axis positively regulates migration of lung squamous H520 cells via Gli1-mediated EMT.

Indexed as

Lung NeoplasmsMicroRNAsCell Line, TumorCell MovementCell ProliferationEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticHumansNeoplasm InvasivenessSOXB1 Transcription FactorsZinc Finger Protein GLI1GLI1 protein, humanMicroRNAsSOX2 protein, humanSOXB1 Transcription FactorsZinc Finger Protein GLI1epithelial-mesenchymal transitionGli1lung squamous cell carcinomaSOX2SOX2-OT

Identifiers

PMID36329576
PMCPMC9637495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.